BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24691053)

  • 1. TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
    Pópulo H; Boaventura P; Vinagre J; Batista R; Mendes A; Caldas R; Pardal J; Azevedo F; Honavar M; Guimarães I; Manuel Lopes J; Sobrinho-Simões M; Soares P
    J Invest Dermatol; 2014 Aug; 134(8):2251-2257. PubMed ID: 24691053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
    Griewank KG; Murali R; Schilling B; Schimming T; Möller I; Moll I; Schwamborn M; Sucker A; Zimmer L; Schadendorf D; Hillen U
    PLoS One; 2013; 8(11):e80354. PubMed ID: 24260374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
    Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations in periocular carcinomas: implications of ultraviolet light in pathogenesis.
    Lin SY; Liao SL; Hong JB; Chu CY; Sheen YS; Jhuang JY; Tsai JH; Liau JY
    Br J Ophthalmol; 2016 Feb; 100(2):274-7. PubMed ID: 26472403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TERT promoter mutation is uncommon in acral lentiginous melanoma.
    Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
    J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.
    Macerola E; Loggini B; Giannini R; Garavello G; Giordano M; Proietti A; Niccoli C; Basolo F; Fontanini G
    Virchows Arch; 2015 Aug; 467(2):177-84. PubMed ID: 26055532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
    Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
    J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of SDHD promoter mutations in various types of melanoma.
    Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
    Scott GA; Laughlin TS; Rothberg PG
    Mod Pathol; 2014 Apr; 27(4):516-23. PubMed ID: 24030752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
    Heidenreich B; Nagore E; Rachakonda PS; Garcia-Casado Z; Requena C; Traves V; Becker J; Soufir N; Hemminki K; Kumar R
    Nat Commun; 2014 Feb; 5():3401. PubMed ID: 24569790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.
    Manrique-Silva E; Rachakonda S; Millán-Esteban D; García-Casado Z; Requena C; Través V; Kumar R; Nagore E
    Br J Dermatol; 2021 Mar; 184(3):504-513. PubMed ID: 32506424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma.
    Gailani MR; Leffell DJ; Ziegler A; Gross EG; Brash DE; Bale AE
    J Natl Cancer Inst; 1996 Mar; 88(6):349-54. PubMed ID: 8609643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular alterations in basal cell carcinoma subtypes.
    Di Nardo L; Pellegrini C; Di Stefani A; Ricci F; Fossati B; Del Regno L; Carbone C; Piro G; Corbo V; Delfino P; De Summa S; Maturo MG; Rocco T; Tortora G; Fargnoli MC; Peris K
    Sci Rep; 2021 Jun; 11(1):13206. PubMed ID: 34168209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis.
    Motaparthi K; Kim J; Andea AA; Missall TA; Novoa RA; Vidal CI; Fung MA; Emanuel PO
    J Cutan Pathol; 2020 Aug; 47(8):710-719. PubMed ID: 32202662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response.
    Griewank KG; Murali R; Scherag A; Schadendorf D
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25755156
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of mutant TERT promoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas.
    Li Y; Cheng HS; Chng WJ; Tergaonkar V
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14402-14407. PubMed ID: 27911794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
    Vazquez Vde L; Vicente AL; Carloni A; Berardinelli G; Soares P; Scapulatempo C; Martinho O; Reis RM
    Melanoma Res; 2016 Apr; 26(2):93-9. PubMed ID: 26709572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
    Cheng KA; Kurtis B; Babayeva S; Zhuge J; Tantchou I; Cai D; Lafaro RJ; Fallon JT; Zhong M
    Ann Diagn Pathol; 2015 Jun; 19(3):146-8. PubMed ID: 25862495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma.
    Hugdahl E; Kalvenes MB; Mannelqvist M; Ladstein RG; Akslen LA
    Br J Cancer; 2018 Jan; 118(1):98-105. PubMed ID: 29123258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis.
    Thomas NE; Edmiston SN; Tsai YS; Parker JS; Googe PB; Busam KJ; Scott GA; Zedek DC; Parrish EA; Hao H; Slater NA; Pearlstein MV; Frank JS; Kuan PF; Ollila DW; Conway K
    Am J Dermatopathol; 2019 Apr; 41(4):264-272. PubMed ID: 30211730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.